Avant Brands Reports Record Fiscal 2024 Results

Rhea-AI Summary

Avant Brands reported record financial results for fiscal year 2024, with gross revenue reaching $40.0 million (+32% YoY) and net revenue of $35.8 million (+36% YoY). The company achieved significant growth in export wholesale revenue, reaching $19.4 million (+107% YoY), driven by strong international demand from Australia, Germany, and Israel.

Q4 2024 highlights include record gross revenue of $12.1 million (+109% YoY) and net revenue of $11.0 million (+127% YoY). However, the company reported a gross loss of $1.8 million in Q4 2024, compared to a $1.0 million profit in Q4 2023, primarily due to biological asset valuations.

Cannabis production increased 19% to 12,643 kg in FY 2024, while sales volume grew 91% to 13,560 kg. The company maintained positive Adjusted EBITDA and Adjusted Net Income for four consecutive quarters, with Q4 2024 achieving $2.3 million and $2.7 million respectively.

Positive

• Record net revenue of $35.8M (+36% YoY)
• Export wholesale revenue up 107% to $19.4M
• Cannabis sales volume increased 91% to 13,560 kg
• Four consecutive quarters of positive Adjusted EBITDA
• Gross margin % adjusted for fair value increased to 45% from 34%

Negative

• Q4 2024 gross loss of $1.8M vs profit of $1.0M in Q4 2023
• Recreational revenue growth to 1% in Q4

• Record Gross and Net Revenue: Generated $40.0 million Gross Revenue and $35.8 million Net Revenue in FY 2024.

• Record Export Wholesale Revenue: Generated $19.4 million in FY 2024 representing a 107% increase over FY 2023.

• Record Cannabis Production: 12,643 kilograms produced in FY 2024, representing a 19% increase over FY 2023.

• Record Cannabis Sold: 13,560 kilograms sold in FY 2024, representing a 91% increase over FY 2023.

KELOWNA, BC / ACCESS Newswire / February 28, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BUP)("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, today released its financial results for fiscal year ended November 30, 2024 ("FY 2024"). The Company achieved significant financial milestones driven by strategic international expansion and operational improvements.

In Q4 2024, Avant Brands reports records across key financial metrics, underscoring the Company's commitment to operational excellence. These highlights include:

• Record Revenues: Gross Revenue increased by 109% to a record $12.1 million compared to Q4 2023, while Net Revenue increased by 127% to a record $11.0 million, demonstrating sustained growth driven by robust international demand.

• Record Export Wholesale Revenue: Export Wholesale Revenue reached a record $7.3 million in Q4 2024, representing a 352% increase over Q4 2023. This reflects the strong demand for Avant's premium flower in global markets, with Export Wholesale Revenue accounting for 66% of Net Revenue, driven by aggressive market expansion into Australia, Germany, and Israel.

• Gross (Loss) Profit: Gross (Loss) Profit decreased to a Gross Loss of $1.8 million in Q4 2024, compared to a Gross Profit of $1.0 million in Q4 2023. This decrease was primarily driven by non-cash impacts to biological asset valuations, partially offset by increased revenues.

• Adjusted EBITDA¹: Achieved Adjusted EBITDA¹ of $2.3 million, marking the fourth consecutive quarter of positive Adjusted EBITDA¹.

• Adjusted Net Income²: Achieved $2.7 million Adjusted Net Income², marking the fourth consecutive quarter of positive Adjusted Net Income².

⁽¹⁾ Adjusted EBITDA is a non-GAAP performance measure. The information is incorporated by reference from the Q4 2024 MD&A filings under "Cautionary Statement Regarding Certain Non-GAAP Performance Measures". The Company's MD&A is available on SEDAR+ at www.sedarplus.ca
⁽²⁾ Adjusted Net Income is a non-GAAP performance measure. The information is incorporated by reference from the Q4 2024 MD&A filings under "Cautionary Statement Regarding Certain Non-GAAP Performance Measures". The Company's MD&A is available on SEDAR+ at www.sedarplus.ca

Avant Brands Founder & CEO Norton Singhavon Comments: "Record revenues, significant international growth, and improved Adjusted Net Income² - Fiscal 2024 was a landmark year for Avant Brands. We are focused on building on this success and creating long-term value for our stakeholders."

⁽²⁾ Adjusted Net Income is a non-GAAP performance measure. The information is incorporated by reference from the Q4 2024 MD&A filings under "Cautionary Statement Regarding Certain Non-GAAP Performance Measures". The Company's MD&A is available on SEDAR+ at www.sedarplus.ca

Fiscal Q4 2024 Financial Highlights (vs. Fiscal Q4 2023):

Revenue:

• Gross Revenue: Record of $12.1 million (+109%)

• Net Revenue: Record of $11.0 million (+127%)

• Export Wholesale Revenue: Record $7.3 million (+352%)

• Recreational Revenue: Increased to $3.0 million (+1%)

• Domestic Wholesale Revenue: Increased to $0.5 million (+122%)

Gross Margin adjusted for fair value adjustments³:

• Gross Margin adjusted for fair value adjustments³: Increased to $4.2 million (+192%)

• Gross Margin % adjusted for fair value adjustments⁴: Increased to 38% (vs. 30%)

⁽³⁾ Gross Margin adjusted for fair value adjustments is a non-GAAP performance measure. The information is incorporated by reference from the Q4 2024 MD&A filings under "Cautionary Statement Regarding Certain Non-GAAP Performance Measures". The Company's MD&A is available on SEDAR+ at www.sedarplus.ca
⁽⁴⁾ Gross Margin % adjusted for fair value adjustments is a non-GAAP performance ratio. The information is incorporated by reference from the Q4 2024 MD&A filings under "Cautionary Statement Regarding Certain Non-GAAP Performance Measures". The Company's MD&A is available on SEDAR+ at www.sedarplus.ca

Cannabis Production and Sales:

• Cannabis Production: 2,785 KG (+2%)

• Cannabis Sales: 4,980 KG sold (+244%)

Commercial Highlights:

• Growth in Key Markets: Ongoing sales growth in Australia, Israel, and Germany, driven by export shipments of Avant's new cultivar portfolio.

Fiscal Year 2024 Financial Highlights (vs. Fiscal Year 2023):

Revenue:

• Gross Revenue: Record of $40.0 million (+32%)

• Net Revenue: Record of $35.8 million (+36%)

• Export Wholesale Revenue: Increased to $19.4 million (+107%)

• Domestic Wholesale Revenue: Increased to $3.3 million (+305%)

Gross Margin adjusted for fair value adjustments³:

• Gross Margin adjusted for fair value adjustments³: Increased to $16.2 million (+78%)

• Gross Margin % adjusted for fair value adjustments⁴: Increased to 45% (vs. 34%)

⁽³⁾ Gross Margin adjusted for fair value adjustments is a non-GAAP performance measure. The information is incorporated by reference from the Q4 2024 MD&A filings under "Cautionary Statement Regarding Certain Non-GAAP Performance Measures". The Company's MD&A is available on SEDAR+ at www.sedarplus.ca
⁽⁴⁾ Gross Margin % adjusted for fair value adjustments is a non-GAAP performance ratio. The information is incorporated by reference from the Q4 2024 MD&A filings under "Cautionary Statement Regarding Certain Non-GAAP Performance Measures". The Company's MD&A is available on SEDAR+ at www.sedarplus.ca

Cannabis Production and Sales:

• Cannabis Production: 12,643 KG (+19%)

• Cannabis Sales: 13,560 KG sold (+91%)

Fiscal 2025 Outlook:

Avant Brands expects to build on its Fiscal 2024 performance by:

• Expanding in existing international markets: Increasing sales in Australia, Germany, Israel, and Portugal;

• Entering new markets: Actively pursuing opportunities in the Czech Republic, Poland, Switzerland, and the UK;

• Refining product portfolio: Aligning offerings with evolving consumer preferences and market demands;

• Optimizing operations: Enhancing profitability through streamlined production and cost management;

• Exploring strategic partnerships: Collaborating with key players in target markets; and

• The Company anticipates continued growth in international sales and overall sales volume.

Contract Growing Partnerships:

To further support its international expansion and meet the growing global demand for premium cannabis, Avant Brands is actively seeking partnerships with domestic licensed producers for contract growing of the Company's unique cultivars. This initiative will supplement existing production capacity and ensure a consistent supply of high-quality products to international clients. This will enable the Company to supplement its existing production capacity and ensure a consistent supply of high-quality products to its international clients.

About Avant Brands Inc.

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BUP) is a leading innovator in premium cannabis products, driven by a commitment to exceptional quality and craftsmanship. As one of Canada's largest indoor producers, the company operates multiple production facilities across the country, cultivating unique and high-quality cannabis strains.

Avant offers a diverse product portfolio catering to recreational, medical, and export markets. Its renowned consumer brands, including blk mkt™, Tenzo™, Cognōscente™, flowr™, and Treehugger™, are available in key recreational markets across Canada. The company's international footprint spans Australia, Israel, and Germany, with its flagship brand blk mkt™ leading the way. Avant also serves qualified medical patients nationwide through its GreenTec™ medical cannabis brand, accessible via the GreenTec Medical portal and trusted partner network.

Avant is a publicly traded company, listed on the Toronto Stock Exchange (TSX) and accessible to international investors through the OTCQX Best Market (OTCQX) and Frankfurt Stock Exchange (FRA). Headquartered in Kelowna, British Columbia, the company operates in strategic locations throughout Canada.

Learn More:

For more information about Avant, including investor presentations and details about its consumer brands, please visit the company website: www.avantbrands.ca

Investor Relations:

For inquiries, please contact Avant Brands Investor Relations at 1-800-351-6358 or ir@avantbrands.ca.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This news release includes certain "forward-looking information" as defined under applicable Canadian securities legislation, encompassing statements regarding Avant Brands Inc.'s ("Avant" or the "Company") plans, intentions, beliefs, and current expectations concerning future business activities and operating performance. Forward-looking information is often identified by words such as "may," "would," "could," "should," "will," "intend," "plan," "anticipate," "believe," "estimate," "expect," or similar expressions. It covers various aspects, including the Company's expectations for future revenue growth. Additionally, it includes plans for international market expansion, and securing agreements with new international partners, reflecting Avant's strategic initiatives. Furthermore, the forward-looking information addresses the Company's efforts in brand building, particularly in establishing and strengthening its premium cannabis brands like blk mkt™. It also encompasses strategies for product development to meet evolving consumer preferences and market trends, as well as the focus on maintaining cost controls and operational efficiencies to enhance profitability and financial performance. Moreover, the forward-looking information considers the anticipated performance of the blk mkt™ brand in the global cannabis industry, supported by successful international expansion and strategic partnerships. Lastly, it mentions the expected availability of the financial statements and the MD&A on the Company's SEDAR+ profile and website, providing investors with comprehensive financial information.

Investors should be aware that forward-looking information involves inherent risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied by such information. Management's current expectations may not accurately predict future events or outcomes. Therefore, investors are cautioned not to place undue reliance on forward-looking information.

Investors are cautioned that forward-looking information is not based on historical fact but instead reflects management's expectations, estimates, or projections concerning future results or events based on the opinions, assumptions, and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance, or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; changes in consumer demand and preferences; changes in general economic, business, and political conditions, including changes in the financial markets; the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; compliance with extensive government regulation; public opinion and perception of the cannabis industry; the impact of COVID-19; and the risk factors set out in the Company's annual information form dated February 28, 2025, filed with Canadian securities regulators and available on the Company's profile on SEDAR+ at www.sedarplus.ca.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated, or expected. Although the Company has attempted to identify important risks, uncertainties, and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated, or intended. Accordingly, readers should not place undue reliance on forward-looking information, which speaks only as of the date of this news release. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by law.

SPECIAL NOTE REGARDING FINANCIAL INFORMATION

This document should be read in conjunction with the Company's audited consolidated financial statements (the "financial statements") and the Company's MD&A for the three month and year ended November 30, 2024, and audited consolidated financial statements for the year ended November 30, 2023. All dollar amounts are referenced in millions of Canadian dollars, except where noted otherwise. The Company's financial statements and MD&A for the three months and year ended November 30, 2024 have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB").

Additional information relating to the Company, including its Annual Information Form for the year ended November 30, 2024, is available on SEDAR+ at www.sedarplus.ca. Information on the Company's website does not form part of and is not incorporated by reference in the Company's MD&A.

SPECIAL NOTE REGARDING NON-GAAP AND OTHER FINANCIAL MEASURES

This document includes references to non-GAAP measures, which include non-GAAP and other financial measures as defined in National Instrument 52-112 - Non-GAAP and Other Financial Measures Disclosure. These financial measures are used by the Company to evaluate its financial performance, financial position or cash flow and include non-GAAP financial measures, non-‍GAAP ratios, total of segments measures, capital management measures, and supplementary financial measures. These financial measures are not defined by IFRS and therefore are referred to as non-GAAP and other financial measures. The non-GAAP and other financial measures used by the Company may not be comparable to similar measures presented by other companies, and should not be considered an alternative to or more meaningful than the most directly comparable financial measure presented in the Company's financial statements, as applicable, as an indication of the Company's performance. Descriptions of the Company's non-GAAP and other financial measures included in this document, and reconciliations to the most directly comparable GAAP measure, as applicable, are provided in the "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of the Company's MD&A for the three month and year ended November 30, 2024, dated February 28, 2025.

SOURCE: Avant Brands Inc.

View the original press release on ACCESS Newswire

FAQ

What was Avant Brands (AVTBF) revenue growth in fiscal year 2024?

Avant Brands achieved record gross revenue of $40.0 million (+32%) and net revenue of $35.8 million (+36%) in FY 2024.

How much cannabis did AVTBF produce and sell in fiscal 2024?

The company produced 12,643 kg (+19%) and sold 13,560 kg (+91%) of cannabis in FY 2024.

What was AVTBF's export wholesale revenue performance in Q4 2024?

Export wholesale revenue reached $7.3 million in Q4 2024, a 352% increase over Q4 2023, representing 66% of net revenue.

What caused the gross loss for AVTBF in Q4 2024?

The gross loss of $1.8 million was primarily driven by non-cash impacts to biological asset valuations, despite increased revenues.

Which international markets is AVTBF targeting for expansion in 2025?

The company is targeting expansion in existing markets (Australia, Germany, Israel, Portugal) and new markets including Czech Republic, Poland, Switzerland, and UK.